Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment

Y Esmaeili, Z Yarjanli, F Pakniya, E Bidram… - Journal of Controlled …, 2022 - Elsevier
Protein homeostasis is a vital process for cell function and, therefore, disruption of the
molecular mechanisms involved in this process, such as autophagy, may contribute to …

Cyclodextrins, from molecules to applications

G Crini, S Fourmentin, É Fenyvesi, G Torri… - Environmental chemistry …, 2018 - Springer
Cyclodextrins are among the most remarkable macrocyclic molecules with significant
theoretical and practical impacts in chemistry and biology. Cyclodextrins belong to the family …

Review of current strategies for delivering Alzheimer's disease drugs across the blood-brain barrier

KH Wong, MK Riaz, Y **e, X Zhang, Q Liu… - International journal of …, 2019 - mdpi.com
Effective therapy for Alzheimer's disease is a major challenge in the pharmaceutical
sciences. There are six FDA approved drugs (eg, donepezil, memantine) that show some …

Overcoming the blood–brain barrier. challenges and tricks for CNS drug delivery

LA Bors, F Erdő - Scientia Pharmaceutica, 2019 - mdpi.com
Treatment of certain central nervous system disorders, including different types of cerebral
malignancies, is limited by traditional oral or systemic administrations of therapeutic drugs …

Cyclodextrins: Assessing the impact of cavity size, occupancy, and substitutions on cytotoxicity and cholesterol homeostasis

L Szente, A Singhal, A Domokos, B Song - Molecules, 2018 - mdpi.com
Cyclodextrins (CDs) are cyclic oligosaccharides; the most common CDs contain six, seven,
or eight glucose units called α-CDs, β-CDs, and γ-CDs, respectively. The use of CDs in …

[HTML][HTML] Access to the CNS: Strategies to overcome the BBB

B Sánchez-Dengra, I González-Álvarez… - International Journal of …, 2023 - Elsevier
The blood–brain barrier (BBB) limits the access of substances to the central nervous system
(CNS) which hinders the treatment of pathologies affecting the brain and the spinal cord …

Cyclodextrins applied to the treatment of lysosomal storage disorders

Y Ishitsuka, T Irie, M Matsuo - Advanced Drug Delivery Reviews, 2022 - Elsevier
Cyclodextrin (CD), a cyclic oligosaccharide, is a pharmaceutical additive that improves the
solubility of hydrophobic compounds. Recent research has focused on the potential active …

Solubility enhancement and application of cyclodextrins in local drug delivery

DH Kim, SE Lee, YC Pyo, P Tran, JS Park - Journal of Pharmaceutical …, 2020 - Springer
Cyclodextrins (CDs) have been used in many pharmaceutical formulations as their
constitution and inherent shape present advantages for drugs with poor aqueous solubility …

Efficacy and ototoxicity of different cyclodextrins in Niemann–Pick C disease

CD Davidson, YI Fishman, I Puskás… - Annals of Clinical …, 2016 - Wiley Online Library
Abstract Objective Niemann–Pick type C (NPC) disease is a fatal, neurodegenerative,
lysosomal storage disorder characterized by intracellular accumulation of unesterified …

Implementation of Water‐Soluble Cyclodextrin‐Based Polymers in Biomedical Applications: How Far Are We?

M Agnes, E Pancani, M Malanga… - Macromolecular …, 2022 - Wiley Online Library
Cyclodextrin‐based polymers can be prepared starting from the naturally occurring
monomers following green and low‐cost procedures. They can be selectively derivatized …